Lancet Market Research Report - Global Forecast till 2024

Global Lancet Market by Type (Safety Lancet, Personal Lancet), End User (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics, Others) and Region - Forecast till 2024

ID: MRFR/MED/1546-CR | May 2019 | Region: Global | 106 pages

Overview


The Global Lancet Market Registered a CAGR of 10.50% during the assessment period, with a market value of USD 1,595.5 Million in 2018.


Lancets are being used for diabetes/glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or severely burned patients. The factors driving the market growth include growing incidence rate of contagious and non-contagious diseases, increasing prevalence of diabetes, and rising inclination towards home care and home diagnostics. However, the risk associated with blood transfusion is expected to hinder the market growth during the forecast period.


Market Dynamics


One of the major applications or functioning areas of lancets is to monitor diabetes in the diabetic population. According to the Centers for Disease Control and Prevention (CDC), 9.4% of the US population are diabetic patients. With the increasing prevalence of diabetes, the demand for lancets is expected to be enormous, thus resulting in the increasing demand for devices and products to monitor and control diabetes, eventually leading to increased use of lancets.


Global Lancet Market Revenue, by End User (USD Million)
 Lancet Market_TOC


Source: MRFR Analysis


Segmentation


The global lancet market based on type has been segmented into safety lancet and personal lancet. Safety lancets can be further divided into push-button safety lancets; pressure activated safety lancets and side button safety lancets. Based on end user, the market is segmented into the hospitals & clinics, diagnostic centers & pathology laboratories, home diagnostics, research and academic laboratories, and others. The hospitals & clinics segment held a major share with a market value of USD 544 Million in 2018.


Key Players


The prominent players in the global lancet market are Terumo Corporation (Japan), Bayer AG (Germany), HTL-STREFA S.A. (Poland), Sarstedt AG & Co. (Germany), Becton, Dickinson and Company (US), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Greiner Bio-One International GmbH (US), Improve Medical Instruments Co. Ltd (US) and others.


Some of the key strategies followed by players operating in the global lancet market were innovation, product development, acquisition, and mergers.


Global Lancet Market Share, 2018 (%)
 Lancet Market_TOC


Source: MRFR Analysis


Regional Analysis


The global lancet market, based on region, is divided into Europe, the Americas, Asia-Pacific, and the Middle East and Africa.


Europe held the largest share of the global lancet market. The Europe market demonstrated substantial growth in the market due to the growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers, etc. and the growth in insulin users. The Americas held a substantial share in the global lancet market owing to the rise in the prevalence of diabetes and the increasing need for a diabetes diagnosis. Asia-Pacific was the fastest growing region in the global market and accounted for 19.1% market share in the global market in 2018. The growth in this region is attributed to the low manufacturing cost and low labor cost in the region. Moreover, the Middle East and Africa showed the least growth owing to low per capita income and lack of adequate healthcare spending.


Industry Updates



  • In October 2017, Abbott Laboratories announced the US Food and Drug Administration approval for Abbott's FreeStyle Libre Flash Glucose Monitoring System for adults. This product approval aims at enhancing the company’s products offering.



  • In August 2017, HTL-STREFA S.A. donated safety lancets to the GLOBAL-MED organization in Poland, which created an initiative called ‘’Ambulans z serca’’ (Ambulance from the heart), to perform free glucose screenings during healthcare events. With this, the company aims to expand its customer base, thus strengthening its presence in the market.



  • In April 2017, Becton, Dickinson, and Company announced the acquisition of C. R. Bard, Inc., a medical technology leader in the fields of vascular, urology, oncology, and surgical specialty products. With this acquisition, BD aims to strengthen its products offering in different clinical areas.


Market Segmentation


Global Lancet Market, by Type



  • Safety Lancet

    • Push Button Safety Lancet

    • Pressure Activated Safety Lancet

    • Side Button Safety Lancet

    • Personal Lancet




Global Lancet Market, by End User



  • Hospitals & Clinics

  • Diagnostic Centers and Pathology Laboratories

  • Home Diagnostics

  • Research and Academic Laboratories

  • Others


Global Lancet Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Lancet Market, Industry Trends

  • Lancet Market, Technology Trends and Assessment


Intended Audience



  • Pharmaceutical Companies

  • Research and Development Organizations

  • Academic Institutes



Frequently Asked Questions (FAQ) :


Lancet Market valuation was USD 1595.5 million in 2018.

The projected CAGR would be USD 1595.5 million during the forecast period.

Risk regarding the blood transfusion process can prevent the market from having regular growth.

The hospitals and clinics segment would dominate.

Europe would enjoy the largest market share.

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

USD YEN EURO GBP INR
TABLE OF CONTENT

2.1 Definition 18

2.2 Scope of the Study 18

2.3 Market Structure 18

3.1 Research Process 19

3.2 Primary Research 20

3.3 Secondary Research 21

3.4 Market Size Estimation 22

3.5 Forecast Model 22

4.1 Overview 23

4.2 Drivers 23

4.2.1 Improving Medical Device Regulations 23

4.2.2 Growing Incidence of Contagious and Non-Contagious Diseases 24

4.2.3 Increasing Prevalence of Diabetes 24

4.2.4 Increasing Inclination Towards Home Healthcare 24

4.3 Restraints 25

4.3.1 Risk Associated with Blood Transfusion 25

5.1 Porter’s Five Forces Model 26

5.1.1 Bargaining power of suppliers 27

5.1.2 Bargaining Power of Buyers 27

5.1.3 Threat of New Entrants 27

5.1.4 Threat of Substitutes 27

5.1.5 Intensity of Rivalry 27

5.2 Supply Chain Analysis 28

6.1 Overview 29

6.2 Safety Lancet 30

6.2.1 Push Button Safety Lancet 30

6.2.2 Pressure Activated Safety Lancet 30

6.2.3 Side Button Safety Lancet 30

6.3 Personal Lancet 32

7.1 Overview 33

7.2 Hospitals & Clinics 35

7.3 Diagnostic Centers and Pathology Laboratories 36

7.4 Home Diagnostics 37

7.5 Research and Academic Laboratories 38

8.1 Overview 39

8.2 Europe 41

8.2.1 Western Europe 43

8.2.1.1 Poland 46

8.2.1.2 Germany 47

8.2.1.3 France 49

8.2.1.4 UK 50

8.2.1.5 Italy 52

8.2.1.6 Rest of Western Europe 53

8.2.2 Eastern Europe 55

8.3 Americas 57

8.3.1 North America 59

8.3.1.1 US 61

8.3.1.2 Canada 63

8.3.2 Latin America 64

8.4 Asia-Pacific 66

8.4.1 Japan 68

8.4.2 China 70

8.4.3 India 71

8.4.4 South Korea 73

8.4.5 Rest of Asia-Pacific 74

8.5 Middle East and Africa 76

8.5.1 UAE 78

8.5.2 Saudi Arabia 80

8.5.3 Egypt 81

8.5.4 Rest of Middle East and Africa 83

9.1 Overview 85

9.2 Company Share Analysis 85

9.3 Pricing of Lancets 86

9.4 Production Capacity of Major Players 86

10.1 Terumo Corporation 87

10.1.1 Company Overview 87

10.1.2 Financial Overview 87

10.1.3 Products/Services Offering 88

10.1.4 Key Developments 88

10.1.5 SWOT Analysis 88

10.1.6 Key Strategies 88

10.2 Bayer AG 89

10.2.1 Company Overview 89

10.2.2 Financial Overview 89

10.2.3 Products/Services Offering 90

10.2.4 Key Developments 90

10.2.5 SWOT Analysis 90

10.2.6 Key Strategies 90

10.3 HTL-STREFA S.A. 91

10.3.1 Company Overview 91

10.3.2 Financial Overview 91

10.3.3 Products/Services Offering 91

10.3.4 Key Developments 92

10.3.5 SWOT Analysis 92

10.3.6 Key Strategies 92

10.4 Sarstedt AG & Co. 93

10.4.1 Company Overview 93

10.4.2 Financial Overview 93

10.4.3 Products/Services Offering 93

10.4.4 Key Developments 93

10.4.5 SWOT Analysis 94

10.4.6 Key Strategies 94

10.5 Becton, Dickinson and Company 95

10.5.1 Company Overview 95

10.5.2 Financial Overview 95

10.5.3 Products/Services Offering 96

10.5.4 Key Developments 96

10.5.5 SWOT Analysis 97

10.5.6 Key Strategies 97

10.6 Abbott Laboratories 98

10.6.1 Company Overview 98

10.6.2 Financial Overview 98

10.6.3 Products/Services Offering 99

10.6.4 Key Developments 99

10.6.5 SWOT Analysis 99

10.6.6 Key Strategies 99

10.7 F. Hoffmann-La Roche Ltd 100

10.7.1 Company Overview 100

10.7.2 Financial Overview 100

10.7.3 Products/Services Offering 101

10.7.4 Key Developments 101

10.7.5 SWOT Analysis 101

10.7.6 Key Strategies 101

10.8 Greiner Bio One International GmbH 102

10.8.1 Company Overview 102

10.8.2 Financial Overview 102

10.8.3 Products/Services Offering 103

10.8.4 Key Developments 103

10.8.5 SWOT Analysis 103

10.8.6 Key Strategies 103

10.9 Improve Medical Instruments Co. Ltd 104

10.9.1 Company Overview 104

10.9.2 Financial Overview 104

10.9.3 Products/Services Offering 104

10.9.4 Key Developments 104

10.9.5 SWOT Analysis 104

10.9.6 Key Strategies 105

11.1 References 106

11.2 Related Reports 106

TABLE 1 GLOBAL LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 30

TABLE 2 GLOBAL LANCET MARKET FOR SAFETY LANCET, BY REGION, 2015–2024 (USD MILLION) 31

TABLE 3 GLOBAL LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 31

TABLE 4 GLOBAL LANCET MARKET FOR PERSONAL LANCET, BY REGION, 2015–2024 (USD MILLION) 32

TABLE 5 GLOBAL LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 34

TABLE 6 GLOBAL LANCET MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2024 (USD MILLION) 35

TABLE 7 GLOBAL LANCET MARKET FOR DIAGNOSTIC CENTERS AND PATHOLOGY LABORATORIES, BY REGION, 2015–2024 (USD MILLION) 36

TABLE 8 GLOBAL LANCET MARKET FOR HOME DIAGNOSTICS, BY REGION, 2015–2024 (USD MILLION) 37

TABLE 9 GLOBAL LANCET MARKET FOR HOME DIAGNOSTICS, BY REGION, 2015–2024 (USD MILLION) 38

TABLE 10 GLOBAL LANCET MARKET, BY REGION, 2015–2024 (USD MILLION) 40

TABLE 11 EUROPE: LANCET MARKET, BY REGION, 2015–2024 (USD MILLION) 41

TABLE 12 EUROPE: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 42

TABLE 13 EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 42

TABLE 14 EUROPE: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 43

TABLE 15 WESTERN EUROPE: LANCET MARKET, BY COUNTRY, 2015–2024 (USD MILLION) 44

TABLE 16 WESTERN EUROPE: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 44

TABLE 17 WESTERN EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 45

TABLE 18 WESTERN EUROPE: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 45

TABLE 19 POLAND: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 46

TABLE 20 POLAND: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 46

TABLE 21 POLAND: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 47

TABLE 22 GERMANY: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 47

TABLE 23 GERMANY: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 48

TABLE 24 GERMANY: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 48

TABLE 25 FRANCE: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 49

TABLE 26 FRANCE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 49

TABLE 27 FRANCE: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 50

TABLE 28 UK: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 50

TABLE 29 UK: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 51

TABLE 30 UK: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 51

TABLE 31 ITALY: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 52

TABLE 32 ITALY: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 52

TABLE 33 ITALY: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 53

TABLE 34 REST OF WESTERN EUROPE: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 53

TABLE 35 REST OF WESTERN EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 54

TABLE 36 REST OF WESTERN EUROPE: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 54

TABLE 37 EASTERN EUROPE: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 55

TABLE 38 EASTERN EUROPE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 55

TABLE 39 EASTERN EUROPE: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 56

TABLE 40 AMERICAS: LANCET MARKET, BY REGION, 2015–2024 (USD MILLION) 57

TABLE 41 AMERICAS: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 58

TABLE 42 AMERICAS: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 58

TABLE 43 AMERICAS: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 59

TABLE 44 NORTH AMERICA: LANCET MARKET, BY COUNTRY, 2015–2024 (USD MILLION) 60

TABLE 45 NORTH AMERICA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 60

TABLE 46 NORTH AMERICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 60

TABLE 47 NORTH AMERICA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 61

TABLE 48 US: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 61

TABLE 49 US: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 62

TABLE 50 US: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 62

TABLE 51 CANADA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 63

TABLE 52 CANADA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 63

TABLE 53 CANADA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 64

TABLE 54 LATIN AMERICA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 64

TABLE 55 LATIN AMERICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 65

TABLE 56 LATIN AMERICA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 65

TABLE 57 ASIA-PACIFIC: LANCET MARKET, BY COUNTRY, 2015–2024 (USD MILLION) 66

TABLE 58 ASIA-PACIFIC: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 67

TABLE 59 ASIA-PACIFIC: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 67

TABLE 60 ASIA-PACIFIC: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 68

TABLE 61 JAPAN: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 68

TABLE 62 JAPAN: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 69

TABLE 63 JAPAN: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 69

TABLE 64 CHINA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 70

TABLE 65 CHINA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 70

TABLE 66 CHINA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 71

TABLE 67 INDIA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 71

TABLE 68 INDIA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 72

TABLE 69 INDIA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 72

TABLE 70 SOUTH KOREA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 73

TABLE 71 SOUTH KOREA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 73

TABLE 72 SOUTH KOREA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 74

TABLE 73 REST OF ASIA-PACIFIC: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 74

TABLE 74 REST OF ASIA-PACIFIC: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 75

TABLE 75 REST OF ASIA-PACIFIC: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 75

TABLE 76 MIDDLE EAST AND AFRICA: LANCET MARKET, BY COUNTRY, 2015–2024 (USD MILLION) 76

TABLE 77 MIDDLE EAST AND AFRICA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 77

TABLE 78 MIDDLE EAST AND AFRICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 77

TABLE 79 MIDDLE EAST AND AFRICA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 78

TABLE 80 UAE: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 78

TABLE 81 UAE: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 79

TABLE 82 UAE: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 79

TABLE 83 SAUDI ARABIA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 80

TABLE 84 SAUDI ARABIA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 80

TABLE 85 SAUDI ARABIA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 81

TABLE 86 EGYPT: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 81

TABLE 87 EGYPT: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 82

TABLE 88 EGYPT: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 82

TABLE 89 REST OF MIDDLE EAST AND AFRICA: LANCET MARKET, BY TYPE, 2015–2024 (USD MILLION) 83

TABLE 90 REST OF MIDDLE EAST AND AFRICA: LANCET MARKET FOR SAFETY LANCET, BY TYPE, 2015–2024 (USD MILLION) 83

TABLE 91 REST OF MIDDLE EAST AND AFRICA: LANCET MARKET, BY END USER, 2015–2024 (USD MILLION) 84

TABLE 92 LANCET PRICE INFORMATION 86

TABLE 93 PRODUCTION CAPACITY 86

FIGURE 1 FDA TIME LINE FOR LANCETS 14

FIGURE 2 MARKET SYNOPSIS 15

FIGURE 3 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL LANCET MARKET 16

FIGURE 4 GLOBAL LANCET SHARE, BY TYPE, 2018 (%) 16

FIGURE 5 GLOBAL LANCET MARKET, BY TYPE, 2016–2024 (USD MILLION) 17

FIGURE 6 GLOBAL LANCET MARKET SHARE, BY END USER, 2018 (%) 17

FIGURE 7 GLOBAL LANCET MARKET, BY END USER, 2016–2024 (USD MILLION) 17

FIGURE 8 GLOBAL LANCET MARKET: MARKET STRUCTURE 18

FIGURE 9 RESEARCH PROCESS OF MRFR 19

FIGURE 10 TOP-DOWN & BOTTOM-UP APPROACH 22

FIGURE 11 MARKET DYNAMICS: GLOBAL LANCET MARKET 23

FIGURE 12 PORTERS FIVE FORCES MODEL 26

FIGURE 13 SUPPLY CHAIN ANALYSIS 28

FIGURE 14 GLOBAL LANCET MARKET, BY TYPE, 2018 (%) 29

FIGURE 15 GLOBAL LANCET MARKET, BY TYPE, 2018 AND 2024 (USD MILLION) 29

FIGURE 16 GLOBAL LANCET MARKET, BY END USER, 2018 (%) 33

FIGURE 17 GLOBAL LANCET MARKET, BY END USER, 2018 AND 2024 (USD MILLION) 33

FIGURE 18 GLOBAL LANCET MARKET, BY REGION, 2018 (%) 39

FIGURE 19 GLOBAL LANCET MARKET, BY REGION, 2018 AND 2024 (USD MILLION) 40

FIGURE 20 EUROPE: LANCET MARKET, BY REGION, 2015–2024 41

FIGURE 21 WESTERN EUROPE: LANCET MARKET, BY COUNTRY, 2015–2024 43

FIGURE 22 AMERICAS: LANCET MARKET, BY REGION, 2015–2024 57

FIGURE 23 NORTH AMERICA: LANCET MARKET, BY COUNTRY, 2015–2024 59

FIGURE 24 ASIA-PACIFIC: LANCET MARKET, BY COUNTRY, 2015–2024 66

FIGURE 25 MIDDLE EAST AND AFRICA: LANCET MARKET, BY COUNTRY, 2015–2024 76

FIGURE 26 GLOBAL LANCET MARKET SHARE ANALYSIS, 2018 (%) 85